Marini J L, Jacobs B L, Sheard M H, Trulson M E
Psychopharmacology (Berl). 1981;73(4):328-31. doi: 10.1007/BF00426460.
The behavioral effects of IP administration of lisuride, a non-hallucinogenic iso-lysergic acid amide analog structurally related to d-lysergic acid diethylamide (LSD), were examined in 15 cats. Ten animals were given saline or 6.25, 12.5, 25, 50, or 100 micrograms/kg of lisuride and observed for 1 h by a rater blind to dose. There was a statistically significant effect of lisuride dose on the frequency of occurrence of the behaviors limb flicking, grooming, and abortive grooming. A time-course study with five cats at the most effective lisuride dose, 50 micrograms/kg, revealed that the frequencies of occurrence of these behaviors reached a maximum during the first 2 h post dose, and were comparable to frequencies after saline by 6 h post dose. An acute tolerance study with four cats scored for 90 min post dose revealed no significant tolerance to a 50 micrograms/kg lisuride test dose administered 6, 24, or 72 h after an initial 50 micrograms/kg dose. Acute cross tolerance studies with four cats scored for 90 min after an initial dose of 50 micrograms/kg of LSD or of lisuride, followed 24 h later by 50 micrograms/kg of lisuride or LSD, revealed no significant cross tolerance. The potency of lisuride relative to LSD was evaluated in six cats that were scored for 60 min following 25 and 50 micrograms/kg of LSD and of lisuride. On a molar basis, scores after lisuride were 51% and 67% those after LSD for limb flicking and grooming. These results indicate that lisuride, a non-hallucinogenic iso-lysergic acid derivative, is a false positive in the animal behavior model for hallucinogens.
研究了15只猫腹腔注射利舒脲(一种与d-麦角酸二乙酰胺(LSD)结构相关的非致幻异麦角酸酰胺类似物)的行为效应。10只动物分别注射生理盐水或6.25、12.5、25、50或100微克/千克的利舒脲,并由对剂量不知情的评估者观察1小时。利舒脲剂量对肢体轻弹、梳理毛发和未遂梳理毛发行为的发生频率有统计学上的显著影响。对5只猫进行的时程研究显示,在最有效的利舒脲剂量(50微克/千克)下,这些行为的发生频率在给药后最初2小时内达到最高,到给药后6小时与注射生理盐水后的频率相当。对4只猫进行的急性耐受性研究显示,在初始剂量50微克/千克后6、24或72小时给予50微克/千克利舒脲测试剂量,未发现明显耐受性。对4只猫进行的急性交叉耐受性研究显示,初始剂量为50微克/千克的LSD或利舒脲,24小时后再给予50微克/千克的利舒脲或LSD,90分钟后评分,未发现明显交叉耐受性。在6只猫中评估了利舒脲相对于LSD的效力,这些猫在注射25和50微克/千克的LSD和利舒脲后60分钟进行评分。以摩尔为基础,利舒脲注射后肢体轻弹和梳理毛发行为的评分分别为LSD注射后的51%和67%。这些结果表明,利舒脲作为一种非致幻异麦角酸衍生物,在致幻剂的动物行为模型中表现为假阳性。